Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Golden breakthrough: French scientists unveil how organogold compounds behave inside cancer cells
Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the…
How oncologists respond to negative trials
FDA Withdrawals and Oncology Drug Use The U.S. Food and Drug Administration’s (FDA) accelerated approval…
Preventable paediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions
More than half of all paediatric cancer deaths worldwide occur in regions of armed conflict,…
UNSW’s rural medical school receives development approval
The federal government’s commitment of $21m to UNSW’s Biomedical Sciences Centre in Wagga Wagga will ensure more medical students are trained in…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.